Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
about
Leishmania RNA virus: when the host pays the tollNatural Leishmania (Viannia) spp. infections in phlebotomine sand flies (Diptera: Psychodidae) from the Brazilian Amazon region reveal new putative transmission cycles of American cutaneous leishmaniasisCutaneous Leishmaniasis Vaccination: A Matter of QualityLipophosphoglycans from Leishmania amazonensis Strains Display Immunomodulatory Properties via TLR4 and Do Not Affect Sand Fly InfectionComparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil.Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.Dynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.Insulin-like growth factor-I induces arginase activity in Leishmania amazonensis amastigote-infected macrophages through a cytokine-independent mechanism.Association between HLA genes and American cutaneous leishmaniasis in endemic regions of Southern BrazilRegulation of Leishmania (L.) amazonensis protein expression by host T cell dependent responses: differential expression of oligopeptidase B, tryparedoxin peroxidase and HSP70 isoforms in amastigotes isolated from BALB/c and BALB/c nude mice.Modulation of Na+/K+ ATPase Activity by Hydrogen Peroxide Generated through Heme in L. amazonensis.Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis.Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophagesSevere Cutaneous Leishmaniasis in a Human Immunodeficiency Virus Patient Coinfected with Leishmania braziliensis and Its Endosymbiotic Virus.Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis.Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters.Malaria-Cutaneous Leishmaniasis Co-infection: Influence on Disease Outcomes and Immune Response.A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.Subversion and Utilization of Host Innate Defense by Leishmania amazonensis.Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.Neurological disease in human and canine leishmaniasis--clinical features and immunopathogenesis.Platelet-activating factor increases reactive oxygen species-mediated microbicidal activity of human macrophages infected with Leishmania (Viannia) braziliensis.Modeling Immune Response to Leishmania Species Indicates Adenosine As an Important Inhibitor of Th-Cell Activation.Annexin A1 Is Involved in the Resolution of Inflammatory Responses during Leishmania braziliensis Infection.Differential Recruitment of Dendritic Cells Subsets to Lymph Nodes Correlates with a Protective or Permissive T-Cell Response during Leishmania (Viannia) Braziliensis or Leishmania (Leishmania) Amazonensis Infection.Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT.Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis.Leishmania amazonensis-Induced cAMP Triggered by Adenosine A2B Receptor Is Important to Inhibit Dendritic Cell Activation and Evade Immune Response in Infected Mice.Crotoxin stimulates an M1 activation profile in murine macrophages during Leishmania amazonensis infection.What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis?Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice.
P2860
Q21131306-191913B6-66B3-41B5-83DA-DA0306EE3FA4Q24396122-79DC2E9D-FBFC-4B00-8A07-C504F7B89E2BQ26752521-7FC5CA51-DB00-4972-8E49-8486C8251A17Q28553439-F098C3D1-7CCB-4125-911C-253BA1E76399Q30365464-CA8AAFC2-F0FF-4B35-934B-8280549124B0Q33633481-D2F8701F-8F04-4E9B-BC9D-365A511AA9C8Q33909932-77728D84-9A6F-444B-9EAC-469EB75F6DF8Q34176956-19B2F405-96C5-4658-A8D8-3F5CCB551EB2Q34247302-39B6FD62-4097-43D4-9E0D-8FAF73C33675Q34702872-0F77F4A1-7ADF-48CB-A5A1-979F101E5561Q35097514-BA83B45E-56C9-4225-A9F4-EBE9DA77102BQ35662370-72F03F16-F183-496D-B12C-FD47EE2EF976Q35786380-7F0F1363-1A11-4811-AE5B-89C92ADC95D5Q35826141-C4937AF9-F642-4012-B732-2FD1DF8C8CA2Q35927732-2F72FA85-6D33-4ED7-AF7C-039C3E79E37EQ36059663-E06C5381-1DDA-4A73-A956-ACAF3284BF7AQ36291428-9815D9C2-C4C1-494F-9CD9-D9533422C022Q36710445-36E301E6-6E1D-4E95-A1BC-B814F2595F98Q36776096-1DE29BCE-131B-43E5-B11B-013E2EA1D220Q36994550-DFA9DEE8-1173-4E9D-98D2-A304C9A42717Q37006391-DCA3C4E3-340E-49CB-B496-B27C5AEF9F4DQ37026407-D352A67F-0E5F-4936-ABBE-F71C2435953DQ37039113-781D30F7-D55D-43BA-BE99-C7D65ED256C9Q37660825-19379307-31B0-4C6D-8755-DA75B5FEA50BQ38008363-8308569D-8F6D-4540-ADBA-679CAF52E412Q38051035-073AA98E-C242-49F1-AAAA-8BF888257676Q38486593-78BE1EB0-309B-4625-989D-784584DBE15EQ38614021-B42933C5-F99A-4612-BAC7-A916BA13232FQ38641911-4076E954-EA12-46A0-8F61-1E547A174C15Q38910414-72670789-4AD7-48CB-9F45-34D8DE9585E2Q38933476-0C9F5844-4D2C-4A64-AF58-65042EC6B4A0Q38934573-DD17B4D5-826D-43D0-AB4C-AE23BB3B2168Q39390935-84FE8872-927E-44C9-B0FF-E0436325875BQ40076714-821F53EC-5A59-48BF-8E7F-31507DA49040Q40101180-005C515A-B96D-4026-9442-728916DFAFC2Q40161712-556CF901-C660-4E7A-B89B-30ED0557217AQ40273988-F80E3331-0217-4345-B6C7-2B5FEB771C5FQ40479047-324C5624-34F5-4BA0-9A07-E77DA458F93BQ40513787-5F1F07E1-DB65-4A47-8A96-0D4F56FD920BQ40785827-E7BBF611-942C-4EFF-8E50-22347A7295C3
P2860
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunopathogenic competences o ...... rican cutaneous leishmaniasis.
@en
Immunopathogenic competences of Leishmania
@nl
type
label
Immunopathogenic competences o ...... rican cutaneous leishmaniasis.
@en
Immunopathogenic competences of Leishmania
@nl
prefLabel
Immunopathogenic competences o ...... rican cutaneous leishmaniasis.
@en
Immunopathogenic competences of Leishmania
@nl
P2093
P1433
P1476
Immunopathogenic competences o ...... erican cutaneous leishmaniasis
@en
P2093
C E P Corbett
C M De Castro Gomes
M D Laurenti
P304
P356
10.1111/J.1365-3024.2009.01116.X
P577
2009-08-01T00:00:00Z